Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD-AF Registry


Goto S., Angchaisuksiri P., Bassand J., Camm A. J., Dominguez H., Illingworth L., ...Daha Fazla

JOURNAL OF THE AMERICAN HEART ASSOCIATION, cilt.8, sa.3, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1161/jaha.118.010510
  • Dergi Adı: JOURNAL OF THE AMERICAN HEART ASSOCIATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: atrial fibrillation, chronic kidney disease, GARFIELD-AF registry, outcomes research, registry, RENAL-FUNCTION, RISK-FACTORS, MULTIPLE IMPUTATION, SYSTEMIC EMBOLISM, WARFARIN USERS, STROKE, ANTICOAGULATION, PREVALENCE, PREVENTION, THROMBOEMBOLISM
  • Gazi Üniversitesi Adresli: Evet

Özet

Background-Using data from the GARFIELD-AF (Global Anticoagulant Registry in the FIELD-Atrial Fibrillation), we evaluated the impact of chronic kidney disease (CKD) stage on clinical outcomes in patients with newly diagnosed atrial fibrillation (AF).